Morgan Stanley Emerging Markets Debt Fund, Inc (MSD) Stock Price

7.28 +0.00 (+0.00%)
Open: 7.27 Vol: 92.6K Day's range: 7.25 - 7.30 Nov 14, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MSD Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 7.26▲ 7.27▼ 7.27▼ 7.30▼ 7.33▼
MA10 7.27▼ 7.27▼ 7.28▼ 7.30▼ 7.40▼
MA20 7.27▼ 7.29▼ 7.29▼ 7.36▼ 7.46▼
MA50 7.29▼ 7.29▼ 7.30▼ 7.42▼ 7.65▼
MA100 7.29▼ 7.33▼ 7.35▼ 7.47▼ 7.52▼
MA200 7.36▼ 7.34▼ 7.38▼ 7.65▼ 7.15▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ -0.003▼ -0.004▼ -0.006▼ -0.015▼
RSI 40.848▼ 37.805▼ 37.371▼ 41.290▼ 40.520▼
STOCH 29.167     11.859▼ 10.256▼ 26.047     19.858▼
WILL %R -75.000▼ -92.308▼ -92.308▼ -83.333▼ -87.234▼
CCI -11.667     -63.467     -77.656     -80.844     -108.813▼
Latest Filters Detected On MSD
MA $MSD Price Crossed Below MA(7) Set Alert
CDL $MSD Engulfing Candlestick Pattern Detected Set Alert
CDL $MSD Marubozu Candlestick Pattern Detected Set Alert
Morgan Stanley Emerging Markets Debt Fund, Inc News
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
Friday, November 14, 2025 03:58 AM
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Cidara Therapeutics, Inc. (Nasdaq: CDTX) ("Cidara"), a biotechnology company developing drug-Fc conjugate (DFC) ...
Merck to Participate in the Jefferies Global Healthcare Conference in London
Thursday, November 13, 2025 03:45 AM
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Jannie Oosthuizen, president, Human Health U.S., and Dr. Marjorie Green, senior vice president and head of ...
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
Saturday, November 08, 2025 09:30 AM
In CORALreef Lipids, adults with or at-risk for atherosclerotic cardiovascular disease (ASCVD) on background lipid-lowering therapies or a documented statin intolerance who received once-daily oral ...
MSD historical stock data
date open high low close volume
14/11/25 7.27 7.30 7.25 7.28 92,600
13/11/25 7.29 7.33 7.26 7.28 134,800
12/11/25 7.33 7.33 7.30 7.30 77,900
11/11/25 7.31 7.33 7.30 7.31 66,400
10/11/25 7.30 7.34 7.27 7.34 106,700
07/11/25 7.26 7.30 7.24 7.26 117,300
06/11/25 7.31 7.33 7.26 7.29 128,300
05/11/25 7.28 7.35 7.28 7.29 129,600
04/11/25 7.35 7.4002 7.26 7.31 136,966
03/11/25 7.40 7.42 7.32 7.34 189,000
Quote Details
52wk Low:6.91
52wk High:8.32
Vol:92.6K
Avg Vol(3m):2M
1Y Chng:-7.26%
1M Chng:-1.22%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 151.88M